1. Home
  2. SUN vs NBIX Comparison

SUN vs NBIX Comparison

Compare SUN & NBIX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Sunoco LP

SUN

Sunoco LP

HOLD

Current Price

$71.74

Market Cap

12.3B

Sector

Energy

ML Signal

HOLD

Logo Neurocrine Biosciences Inc.

NBIX

Neurocrine Biosciences Inc.

HOLD

Current Price

$163.40

Market Cap

13.2B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
SUN
NBIX
Founded
1960
1992
Country
United States
United States
Employees
N/A
N/A
Industry
Integrated oil Companies
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Energy
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
12.3B
13.2B
IPO Year
2012
1996

Fundamental Metrics

Financial Performance
Metric
SUN
NBIX
Price
$71.74
$163.40
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
6
22
Target Price
$68.33
$180.91
AVG Volume (30 Days)
495.5K
1.4M
Earning Date
05-05-2026
05-05-2026
Dividend Yield
5.45%
N/A
EPS Growth
N/A
41.95
EPS
N/A
3.30
Revenue
$25,201,000,000.00
$161,626,000.00
Revenue This Year
$63.67
$24.73
Revenue Next Year
$0.84
$13.14
P/E Ratio
$26.93
$49.52
Revenue Growth
11.05
977.51
52 Week Low
$47.98
$122.14
52 Week High
$78.11
$186.12

Technical Indicators

Market Signals
Indicator
SUN
NBIX
Relative Strength Index (RSI) 48.14 41.69
Support Level $62.14 $153.96
Resistance Level $72.88 $169.57
Average True Range (ATR) 2.01 6.49
MACD -0.74 -2.18
Stochastic Oscillator 20.57 14.40

Price Performance

Historical Comparison
SUN
NBIX

About SUN Sunoco LP

Sunoco LP is engaged in the distribution of motor fuels to independent dealers, distributors, and other commercial customers as well as the distribution of motor fuels to end-use customers at retail sites operated by commission agents. It is a growth-oriented master limited partnership (MLP) that operates as a wholesale and retail fuel distributor in the United States. The firm operates through the Fuel Distribution; Pipeline Systems; Refinery and Terminals segments. It generates the majority of its revenue from the Fuel Distribution segment. It distributes motor fuel to convenience stores, dealers, and commercial customers in various states.

About NBIX Neurocrine Biosciences Inc.

Neurocrine Biosciences Inc is a biopharmaceutical firm focused on the research, development, and commercialization of treatments for neurological, psychiatric, endocrine, and immunological disorders. Its portfolio includes therapies for conditions such as tardive dyskinesia, chorea associated with Huntington's disease, classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency, and treatments for endometriosis and uterine fibroids. The company also maintains a pipeline of drug candidates in various stages of clinical and preclinical development across its therapeutic areas, including small molecules, peptides, proteins, antibodies, conjugates, and gene therapies. It derives revenue from the sale of its pharmaceutical products.

Share on Social Networks: